Medication info
Teneream Extended-Release Tablet 20/1000 mg

Teneream Extended-Release Tablet 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletTeneligliptin Hydrochloride Hydrate›25.96mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Pink, double-sided, convex oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202805 · Approved 2022.07.06 · Insurance code 648104790

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment with this medicine may be started at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because such a switch may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medication is used to assist patients with type 2 diabetes in controlling their blood glucose levels. It is particularly effective when used in conjunction with dietary and exercise regimens to improve blood sugar levels more effectively. With the combination of Teneligliptin and Metformin, it exerts a synergistic effect on blood glucose control. Regular use can help maintain smooth blood glucose management. This medication is intended to enhance overall blood glucose control ability.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment with this medicine may be started at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because such a switch may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication helps regulate blood glucose levels. However, it can very rarely cause a serious condition known as lactic acidosis, which can be life-threatening, so caution is necessary. When used with other diabetes medications, there is a risk of hypoglycemia, so blood glucose levels should be closely monitored. This medication is not administered to patients with moderate or worse kidney impairment, or serious heart problems such as heart failure or acute myocardial infarction. Prior to and after tests using iodinated contrast agents, this medication should be discontinued for a certain period, and it should be resumed only after confirming normal kidney function. It is also safest not to use this medication in women who are pregnant or possibly pregnant, or in patients with severe liver impairment. This medication can increase the risk of hypoglycemia, so patients taking insulin or sulfonylureas should be well aware of hypoglycemic symptoms. If severe abdominal pain, vomiting, difficulty breathing, or lethargy occurs during use, immediate medical attention should be sought. Additionally, although rare, serious side effects such as interstitial pneumonia and vesicular skin disorders have been reported, so it is crucial to promptly report any abnormal symptoms. This medication requires dosage adjustment based on kidney function, and elderly patients should undergo regular kidney function tests. In case of overdose, blood dialysis can remove the drug, so if overdose is suspected, immediate medical attention is required. Alcohol consumption can increase the risk of lactic acidosis, so abstaining from drinking during treatment is advised. Vitamin B12 levels may decrease, so it is recommended to check regularly through blood tests. Lastly, when performing tasks that require attention, such as driving or operating machinery, one should be aware of symptoms of hypoglycemia and lactic acidosis.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • dermatitis herpetiformis
  • acute pancreatitis
  • dizziness
Show 130 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colonic polyps
  • duodenal ulcers
  • gastroesophageal reflux
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium levels
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • tremor
  • headache
  • asthenia
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • diaphoresis
  • diabetic retinopathy
  • decreased vision
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • decreased neutrophil count
  • abnormal blood glucose
  • increased blood glucose
  • increased blood pressure
  • hepatic encephalopathy
  • lumbar spinal canal stenosis
  • intravertebral disc protrusion
  • intravertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureterolithiasis
  • urolithiasis
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • biliary obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • whitecoat hypertension
  • bleeding
  • increased blood glucose
  • abnormal sputum
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid injury
  • ligament sprain
  • lip injury
  • contusion
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • ovarian cyst
  • vulvar pruritus
  • menopausal symptoms
  • pressure ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pink, double-sided, convex oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.